ICUI Stock Analysis: Buy, Sell, or Hold?
ICUI - ICU Medical Inc
$119.10
-3.89 (-3.17%)
▼
5d:
-5.8%
30d:
-5.51%
90d:
-17.81%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When ICUI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ICUI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ICUI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$233.02
Based on 9.1% avg growth
INTRINSIC VALUE TODAY
$144.69
17.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICUI is currently trading at $119.09, which is considered oversold relative to its 30-day fair value range of $119.72 to $127.43. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.2) compared to its historical average (16.2). Remarkably, the market is currently pricing in an annual earnings decline of 6.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ICUI is in a strong downtrend. The price is currently testing key support at $115.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $174.17 (+41.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ICUI is in a strong downtrend. The price is currently testing key support at $115.61. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $174.17 (+41.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$119.72 -
$127.43
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 41.6% below Wall St target ($174.17)
- CAUTION: Recommendation downgraded due to -5.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$119.72 -
$127.43
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$115.61
Resistance Level
$132.70
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.18
Wall Street Target
$174.17
(+41.6%)
Revenue Growth (YoY)
-12.3%
Earnings Growth (YoY)
-23.8%
Profit Margin
2.1%
Valuation Discount vs History
-6.7% cheaper
PE vs Historical
13.2 vs 16.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.7%
(market-implied from PE analysis)
1-Year Target
$114.75
(-7%)
2-Year Target
$107.06
(-13%)
3-Year Target
$99.89
(-19%)
3-Yr Target (if PE normalizes)
(PE: 13→16)
$122.77
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 14.2%)
$306.59
(+149%)
Base:
(SPY PE: 13.2, Growth: 14.2%)
$183.34
(+49%)
Bear:
(PE: 11.2, Growth: 14.2%)
$155.84
(+27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Forward PE: 15.48 | Forward EPS (Implied): $7.95
Bull Case
$148.51
(+21%)
Analyst growth 15.0%, PE expands to 16.3
Base Case
$122.99
(0%)
Market implied 0.0%, PE stable at 15.5
Bear Case
$94.09
(-24%)
Severe decline -15.0%, PE contracts to 13.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.2 to 16.2
Stabilization Target:
$151.17
(+22.9%)
PE Expansion Potential:
+22.9%
Share & Embed Analysis
Last updated: May 15, 2026 1:49 PM ET
Data refreshes hourly during market hours. Next update: 2:49 PM
Data refreshes hourly during market hours. Next update: 2:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICUI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$577 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 53 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$180 | 49 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 64 BUY |
